Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Aavika Shinde
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Short Bowel Syndrome Drugs Market | Analysis by Industry Trends, Size, Share, Company Overview, Growth, Development and Forecast

% of readers think this story is Fact. Add your two cents.


The buyer may better understand the different drivers and restraints and how they will affect the market over the projected term with the use of a Short Bowel Syndrome Drugs Market research study. It also sheds light on recent advancements, new product releases, partnerships, mergers, and acquisitions that a number of important companies and brands have embraced. The best Short Bowel Syndrome Drugs Market study provides CAGR estimates for the base year 2022, the historic year 2021, and the forecast period of 2023–2030 in addition to evaluations of all the market drivers and constraints, which are primarily derived from SWOT analysis.

The superior Short Bowel Syndrome Drugs Market research study has been organized using the knowledge and creativity of a group of analysts, managers, forecasters, and researchers. The company profile, product details, capacity, production value, and market shares for each company from 2023 to 2030 are shown in this market report. This market study includes company profiles of major industry participants, a detailed examination of their core strengths, and a competitive landscape drawing. This expertly written study goes into great detail and focuses on major segments, market share, primary and secondary drivers, and geographic analysis. In order to create a great Short Bowel Syndrome Drugs Market business report, excellence and intelligibility are two of the most important criteria that must be met.

Explore Further Details about This Research Short Bowel Syndrome Drugs Market Report https://www.databridgemarketresearch.com/reports/global-short-bowel-syndrome-drugs-market

Short bowel syndrome is related with small intestine surgeries. It is characteristically acquired over the individual’s lifespan and genetically occurs only in few cases.  Currently, there is no cure for short bowel syndrome and the treatment is targeted toward its symptoms. In some cases, short bowel syndrome can be life-threatening, but the disease can be managed through effective medication. In addition to this, government bodies are directly taking part in boosting the confidence of local manufacturers through various initiatives.

Data Bridge Market Research analyses a growth rate in the global short bowel syndrome drugs market in the forecast period 2022-2029. The expected CAGR of global short bowel syndrome drugs market is tend to be around 15% in the mentioned forecast period. The market was valued at USD 1.44 billion in 2021, and it would grow upto USD 4.40 billion by 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Short bowel syndrome drugs is a type of rare gastrointestinal disease wherein a patient either lose a large amount of intestine or are born with inadequate amount of intestine as well as dysfunctional intestine that finally results in the malnutrition because it cannot effectively absorb the nutrients from the food.  

Drivers

  • Increased Demand of Intravenous Supplementation of Fluids

There is a rising demand for intravenous supplementation of fluids for maintaining the normal hydration and urinary flow for patients who are suffering from this syndrome. Several key manufacturers in the short bowel syndrome market are making efforts to meet this demand, since these patients suffer from complications such as hyponatremia, dehydration, and chronic renal failure. Hypomagnesemia is caused by malabsorption of magnesium because of the loss of the distal ileum, several manufacturers are producing magnesium supplements to help the patients achieve adequate hydration.

  • Prevalence of Short Bowel Syndrome

Incidence of short bowel syndrome has increased across the globe in the past few years. The increasing patients number on total parenteral nutrition has led to the increase in the market growth. The occurrence of short bowel syndrome is projected to be about four people per million, and the occurrence is about three people per million. Although the exact prevalence of the disease is not clear, it is expected based on the number of people on parenteral nutrition.

Recent Development

  • In June 2021, VectivBio Holding AG announced that the FDA had granted orphan drug designation to Apraglutide. It is a next-generation, long-acting GLP-2 analog that is being developed for rare gastrointestinal diseases and used for the prevention of acute graft-versus-host disease (aGVHD).
  • In April 2021, Hanmi Pharm. Co. Ltd. announced that the U.S. FDA had granted fast-track designation to its short-bowel syndrome therapy, LAPS GLP-2 Analog (HM15912). LAPS GLP-2 Analog is a new biopharmaceutical that has been developed for short-bowel syndrome with the company’s platform technology, Labscovery. The disorder occurs in approximately 24.5 out of 100,000 newborns and majorly affects the growth of children and adolescents, with a survival rate under 50%.

Global Short Bowel Syndrome Drugs Market Scope

The global short bowel syndrome drugs market is segmented on the basis of drug class, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

  • Glucagon-like Peptide
  • Anti-Diarrheal
  • Histamine Blockers
  • Proton Pump Inhibitors
  • Growth Hormone
  • Others

Route of Administration

  • Oral
  • Parenteral
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • HospitalPharmacy
  • Online Pharmacy
  • Retail Pharmacy

Key players operating in the global short bowel syndrome drugs market include:

  • Takeda Pharmaceutical Company Limited (Japan)
  • Johnsons & Johnsons Services Inc (U.S.)
  • Boehringer Ingelheim International GmbH (Germany)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Sanofi (France)
  • GSK Plc. (U.K.)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (U.S.)
  • Amneal Pharmaceuticals LLC. (U.S.)
  • Alvogen (U.S)
  • Hikma Pharmaceuticals PLC (U.K.)

Key Insights Of Short Bowel Syndrome Drugs Market Report

  • The report comprises a detailed analysis of different segments and offers market valuations between 2023 to 2030.
  • This study presents the analytical depiction of the Short Bowel Syndrome Drugs Market with the current trends and future estimations to determine the imminent investment pockets
  • The report also reveals information with respect to key drivers, restraints, and opportunities coupled with a comprehensive analysis of the global Short Bowel Syndrome Drugs Market
  • The forecast period of the market is assessed from 2024 to 2030 to highlight the Short Bowel Syndrome Drugs Marketgrowth scenario.
  • Porter’s five forces analysis establishes the effectiveness of the buyers and suppliers in the business line.
  • The key players in the industry are profiled to gain an understanding of the strategies adopted by them.
  • This report provides the current trends and future estimations during the forecast period, which in turn aids in identify the prevailing market opportunities.

The company portfolio includes company synopsis, operating business sectors, business overview, product/service categories, and recent growth strategies adopted by them.

Browse Related Reports:

Personal Protective Equipment Packaging Market Size And Share Analysis Report,
Healthcare Mobility Solutions Market by Size, Share, Forecast, & Trends
Life Science Analytics Market Size Report- Industry Growth Analysis
Industrial Crane Market Size, Industry Share Forecast
Data Center Networking Market Size, Share, Growth | Opportunities,
Location-baSEd SErvices (LBS) and real time location systems (RTLS) Market Size, Share Analysis Report
Glycomics Market Size, Share, Growth Analysis
High Pressure Protective Packaging Film Market Size, Share, Growth
High Strength Aluminum Alloys Market Demand,Size ,Share, Industry
Polypropylene Packaging Film Market Size, Analysis and Forecast
Cast Acrylic Sheets Market Size, Share, Trends & Forecast
Coating Additives Market Size And Share Analysis Report,
Glass Substrate Market by Size, Share, Forecast, & Trends
Membranes Market Size Report- Industry Growth Analysis
Nanoparticles Market Size, Industry Share Forecast
Nitrile Butadiene Rubber (NBR) Market Size, Share, Growth | Opportunities,
Sound Deadening Sprays Market Size, Share Analysis Report
UPF Sun Protective Clothing Market Size, Share, Growth Analysis
Coal-Based Activated Carbon Market Size, Share, Growth
Poultry Feed Preservatives Market Demand,Size ,Share, Industry
Organic Ruminant Feed Market Size, Analysis and Forecast
Greenhouse Drip Irrigation System Market Size, Share, Trends & Forecast
Viscosity Reducing Agents Market Size And Share Analysis Report,
Lithium Iron Phosphate (LFP) Batteries Market by Size, Share, Forecast, & Trends

About Data Bridge Market Research:

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email – [email protected] 



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Lion’s Mane Mushroom

Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes:

Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.

Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.

Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.

Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.

Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.

Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules. Today Be 100% Satisfied Or Receive A Full Money Back Guarantee Order Yours Today By Following This Link.

Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.